MALLINCKRODT PHARMA IP TRADING D A C has a total of 29 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2005. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are SHANGHAI OUBANG MEDICAL MAN CO LTD, INNOVATION TECH INC and REGEN LAB SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 15 | |
#2 | United States | 9 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising | |
#4 | Enzymes | |
#5 | Peptides | |
#6 | Microorganisms | |
#7 | Syringes | |
#8 | Fermentation | |
#9 | Diagnosis and surgery | |
#10 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Koopman Jacob | 12 |
#2 | Martyn Glen | 6 |
#3 | Bout Abraham | 5 |
#4 | Grimbergen Joseph | 5 |
#5 | Schutte Eliane | 4 |
#6 | Senderoff Richard I | 4 |
#7 | Jiang Shan | 3 |
#8 | Bishop Paul D | 3 |
#9 | Meyer Jeffrey D | 3 |
#10 | Greenhalgh Paul | 3 |
Publication | Filing date | Title |
---|---|---|
US2017182135A1 | Dry powder fibrin sealant | |
AU2014224594A1 | Powder formulation comprising thrombin and fibrinogen | |
AU2012280218A1 | Formulations for wound therapy | |
AU2011204557A1 | Fibrinogen preparations enriched in fibrinogen with an extended alpha chain | |
AU2006330923A1 | Method for activating prethrombin-1 |